Effect of alpha-lipoic acid on memory, oxidation, and lifespan in SAMP8 mice

Journal of Alzheimer's Disease

Volumn 32, Issue 2, 2012, Pages 447-455

  Farr, Susan A ^a   Price, Tulin O ^a   Banks, William A ^b,c   Ercal, Nuran ^d   Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

Author keywords

Alpha lipoic acid; antioxidants; learning and memory; lifespan; SAMP8 mice

Indexed keywords

GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DRUG MECHANISM; LEARNING; LIFESPAN; MAZE TEST; MEMORY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RECOGNITION; SENESCENCE ACCELERATED MOUSE; SURVIVAL RATE;

EID: 84867488056     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120130     Document Type: Article

References (60)

1. HarmanD(2002) Alzheimer's disease: Role of aging in pathogenesis. Ann N Y Acad Sci 959, 384-395.
2. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23, 134-147.
3. Polidori MC, Griffiths HR, Mariani E, Mecocci P (2007) Hallmarks of protein oxidative damage in neurodegenerative diseases: Focus on Alzheimer's disease. Amino Acids 32, 553-559.
4. Skulachev VP, Anisimov VN, Antonenko YN, Bakeeva LE, Chernyak BV, Erichev VP, Filendo OF, Kalinia NI, Kapelko VI, Kolosova NG, Kopin BP, Korshunova GA, Lichinitser MR, Obukhova LA, Pasyukova EG, Pisarenko OI, Roginsky VA, Ruuge EK, Senin II, Severina II, Skulachev MV, Spivak IM, Tashlitsky VN, Tkachuk VA, Vyssokikh MY, Yaguzhinsky LS, Zorov DB (2009) An attempt to prevent senescence: A mitochondrial approach. Biochim Biophys Acta 1787, 437- 461.
5. Suh JH, Shigeno ET, Morrow JD, Cox B, Rocha AE, Frei B, Hagen TM (2001) Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid. FASEB J 15, 700-706.
6. Lynch MA (2001) Lipoic acid confers protection against oxidative injury in non-neuronal and neuronal tissue. Nutr Neurosci 4, 419-438.
7. Packer L, Tritschler HJ,Wessel K (1997) Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med 22, 359-378.
8. Holmquist L, Stuchbury G, Berbaum K, Muscat S, Yougn S, Hager K, Engel J, Munch G (2007) Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacol Ther 113, 154-164.
9. Atukeren P, Aydin S, Uslu E, Gumustas MK, Cakatay U (2010) Redox homeostasis of albumin in relation to alphalipoic acid and dihydrolipoic acid. Oxid Med Cell Longev 3, 206-213.
10. Maczurek A, Hager K, Kenklies M, Sharman M, Martins R, Engel J, Carlson DA,Munch G (2008) Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Adv Drug Deliv Rev 60, 1463-1470.
11. Taylor NL, Heazlewood JL, DayDA, MillarAH(2004) Lipoic acid-dependent oxidative catabolism of alpha-keto acids in mitochondria provides evidence for branched-chain amino acid catabolism in Arabidopsis. Plant Physiol 134, 838- 848.
12. Stoll S, Hartmann H, Cohen SA, Muller WE (1993) The potent free radical scavenger -lipoic acid improves memory in aged mice: Putative relationship to NMDA receptor deficits. Pharmacol Biochem Behav 46, 799-805.
13. Nagesh BabuG,Kumar A, Singh RL (2011) Chronic pretreatment with acetyl-L-carnitine and ±DL-lipoic acid protects against acute glutamate-induced neurotoxicity in rat brain by altering mitochondrial function. Neurotox Res 19, 19-329.
14. Baydas G, Donder E, Kiliboz M, Sonkaya E, Tuzcu M, Yasar A, Nedzvetskii (2004) Neuroprotective by alpha-lipoic acidin streptozotocin-induced diabetes. Biochemistry (Mosc) 69, 1001-1005.
15. Jesadason EP, Masilamoni JG, Ashok BS, Baben B, Arul V, Jesudoss KS, Jebaraj WC, Dhandayuthapani S, Vignesh S, Jayakumar R (2008) Inhibitory effects of short-term administration of DL-alpha-lipoic acid on oxidative vulnerable induced by Abeta amyloid fibrils (25-35) in mice. Mol Cell Biochem 311, 145-156.
16. Siedlak SL, Casadesus G,Webber KM, Pappola MA, Atwood CS, Smith MA, Perry G (2009) Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease. Free Radic Res 43, 156-164.
17. Quinn JF, Bussiere JR, Hammond RS, Montine TJ, Henson E, Jones RE, Stackman RW Jr (2007) Chronic dietary alphalipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiol Aging 28, 213-225.
18. Cho JY, UmHS, Kang EB, Cho IH, Kim CH, Cho JS, Hwqant DY (2010) The combination of exercise training and alphalipoic acid treatment has therapeutic effects on the pathogenic phenotypes of Alzheimer's disease in NSE/APPsw-transgenic mice. Int J Mol Med 25, 337-346.
19. Hager K, Kenklies M, McAfoose J, Engel J,M̈unch G (2007) Alpha-lipoic acid as a new treatment option for Alzheimer's disease - A 48 months follow-up analysis. J Neural Transm SUPPL72, 189-193.
20. Holmquist L, Stuchbury G, Berbaum K, Muscat S, Young S, Hager K, Engel J, M̈unch G (2007) Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacol Ther 113, 154-164.
21. Yagi H, Katoh S, Akiguchi I, Takeda T (1988) Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in recent memory. Neurosci Biobehav Rev 474, 86-93.
22. Flood JF, Morley JE (1998) Learning and memory in the SAMP8 mouse. Neurosci Biobehav Rev 22, 1-20.
23. Morley JE, Kumar VB, Bernardo AE, Farr SA, Uezu K, Tumosa N, Flood JF (2000) -Amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 21, 1761-1767.
24. Manich G, Mercader C, delValle J, Duran-Vilaregut J, Camins A, Pall̀as M, Vilaplana J, Pelegri C (2011) Characterization of amyloid- granules in the hippocampus of SAMP8 mice. J Alzheimers Dis 25, 535-546.
25. Morley JE, Farr SA, Flood JF (2002) Antibody to amyloid beta protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice. Neurobiol Learn Mem 78, 125- 138.
26. Kumar VB, Farr SA, Flood JF, Kamelesh V, Franko M, BanksWA,Morley JE (2000) Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides 21, 1769-1775.
27. Butterfield DA, Howard BJ, Yatin S, Akkeb KL, Carney JM (1997) Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl- phenylnitrone. Proc Natl Acad Sci U S A 94, 674-678.
28. Sato E, Kurokawa T, Oda N, Ishibashi S (1996) Early appearance of abnormality of microperoxisomal enzymes in the cerebral cortex of senescence-accelerated mouse. Mech Ageing Dev 92, 175-184.
29. Fujibayashi Y, Yamamoto S, Waki A, Jibusgu Hm Yonekura Y (1998) Increased mitochondrial DNA deletion in the brain of SAMP8, a mouse model for spontaneous oxidative stress brain. Neurosci Lett 254, 109-112.
30. Farr SA, Poon HF, Dogrukol-Ak D, Drake J, Banks WA, Eyerman E, Butterfield DA, Morley JE (2003) The antioxidants -lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem 84, 1173-1183.
31. Poon HF, Farr SA, Thongboonkerd V, Lynn BC, Banks WA, Morley JE, Klein JB, Butterfield DA (2005) Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: Implications for aging and age-related neurodegenerative disorders. Neurochem Int 45, 159-168.
32. Sawada M, Carlson JC (1987) Changes in superoxide radical and lipid peroxide formation in the brain, heart and liver during the lifetime of the rat. Mech Ageing Dev 41, 125-137.
33. Aerts AM, Zabrocki P, Govaert G, Mathys J, Carmona- Gutierrez D, Madeo F,Winderickx J, Cammue BP, Thevissen K (2009) Mitochrondrial dysfunction leads to reduced chronological lifespan and increased apoptosis in yeast. FEBS Lett 582, 113-117.
34. Nohl H, Hegner D (1978) Do mitochondria produce oxygen radicals in the vivo? Eur J Biochem 82, 563-567.
35. Stadtman ER (1992) Protein oxidation and aging. Science 257, 1220-1224.
36. Sohal RS, Ku HH, Agarwal S, Forester MJ, Lal H (1994) Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech Ageing Dev 74, 121-133.
37. Lee HC, Wei YH (2012) Mitochondria and aging. Adv Exp Med Biol 942, 311-327.
38. Sohal RS, Svensson I, Sohal BH, Brunk UT (1989) Superoxide anion radical production in different animal species. Mech Ageing Dev 49, 129-135.
39. Orr WC, Sohal RS (1994) Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 263, 1128-1130.
40. Sampayo JN, Olsen A, Lithgow GJ (2003) Oxidative stress in Caenorhabditis elegans: Protective effects of superoxide dismutase/catalase mimetics. Aging Cell 2, 319-326.
41. Lipman RD, Bronson RT, Wu D, Smith DE, Prior R, Cao G, Han SN, Martin KR, Meydani BN, Meydajni M (1998) Disease incidence and longevity are unaltered by dietary antioxidant supplementation initiated during middle age in C57BL/6 mice. Mech Ageing Dev 103, 269-284.
42. Lee CK, Pugh TD, Klopp RG, Edwards J, Allison DB,Weinruch R, Prolla TA (2004) The impact of alpha-lipoic acid, coenzyme Q10 and caloric restriction on life span and gene expression patterns in mice. Free Radic Biol Med 36, 1043- 1057.
43. Spindler SR, Mote PL (2007) Screening candidate longevity therapeutics using gene-expression arrays. Gerontology 53, 306-321.
44. Weindruch R, Walford RL (1988) The retardation of aging and disease by dietary restriction. Charles C Thomas, Springfield, IL.
45. Selman C, McLaren JS, Mayer C, Ducan JS, Collins AR, Duthie GG, Redman P, Speakman JR (2008) Lifelong alphatocopherol supplementation increases the median life span of C57BL/6 mice in the cold but has only minor effects on oxidative damage. Rejuvenation Res 11, 83-96.
46. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C (2008) Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev (3 CD004183
47. Banks WA, Morley JE, Farr SA, Price TO, Ercal N, Vidaurre I, Schally AV (2010) Effects of growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice. Proc Natl Acad Sci U S A 107, 22272-22277.
48. Caraballoso M, Sacristan M, Serra C, Bonfill X (2003) Drugs for preventing lung cancer in healthy people. Cochrane Database Syst Rev (2 CD002141
49. Rossi C, Di Lena A, La Sorda R, Lattanzio R, Antilini L, Patassini C, Piantelli M, Alberti S (2008) Intestinal tumour chemoprevention with the antioxidant lipoic acid stimulates the growth of breast cancer. Eur J Cancer 44, 2696-2704.
50. Cakatay U, Kayali R, Sivas A, Tekeli F (2005) Prooxidant activities of alpha-lipoic acid on oxidative protein damage in the aging rat heart muscle. Arch Gerontol Geriatr 40, 231-240.
51. Palacios HH, Yendluri BB, Parvathaneni K, Shadlinski VB, Obrenovich ME, Leszek J, Gokhman D, Gasiorowski K, Bragin V, Aliev G (2011) Mitochondrion-specific antioxidants as drug treatments for Alzheimer disease. CNS Neurol Disord Drug Targets 10, 149-162.
52. Morley JE, Armbrecht HJ, Farr SA, Kumar VB (2012) The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease. Biochim Biophy Acta 1822, 650-656.
53. Clark TA, Lee HP, Rolston RK, Zhu X, Marlatt MW, Castellani RJ, Nunomura A, Casadesus G, Smith MA, Lee HG, Perry G (2010) Oxidative stress and its implications for future treatments and management of Alzheimer's disease. Int J Biomed Sci 6, 225-227.
54. Lee HP, Zhu X, Casadesus G, Castellani RJ, Nunomura A, Smith MA, Lee HG, Perry G (2010) Antioxidant approaches for the treatment of Alzheimer's disease. Expert Rev Neurother 10, 1201-1208.
55. Woollin SD, Jones PJ (2003) Alpha-lipoic acid and cardiovascular disease. J Nutr 133, 3327-3330.
56. Ghibu S, Richard C,Vergely C, Zeller M, CottinY, Rochette L (2009) Antioxidant properties of an endogenous thiol: Alphalipoic acid, useful in the prevention of cardiovascular diseases. J Cardiovasc Pharmacol 54, 391-398.
57. Morris MC (2009) The role of nutrition in Alzheimer's disease: Epidemiological evidence. Eur J Neurol 16(SUPPL1 1-7.
58. Devore EE, Grodstein F, van Rooij FJ, Hofman A, Stampfer MJ,Witterman JC, Breteler MM (2010) Dietary antioxidants and long-term risk of dementia. Arch Neurol 67, 819-825.
59. Brewer GJ (2010) Why vitamin E therapy fails for treatment of Alzheimer's disease. J Alzheimers Dis 19, 27-30.
60. Pavlik VN, Doody RS, Rountree SD, Darby EJ (2009) Vitamin E use is associated with improved survival in an Alzheimer's disease cohort. Dement Geriatr Cogn Disord 28, 536-540.